Tumores Urológicos

M-A | Eficácia e segurança da terapia sistêmica de primeira linha para o carcinoma de células renais metastático.

10 Fev, 2022 | 12:59h

Efficacy and Safety of First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis – European Urology Open Science

---

M-A | Eventos adversos da imunoterapia para pacientes com câncer urológico em estudos clínicos.

4 Fev, 2022 | 16:30h

Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis – European Urology

 

Comentário no Twitter

Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysishttps://t.co/cnLe3oxATE@ricautor @spsutkaMD @MRoupret @AndreaNecchi @pcvblack pic.twitter.com/EmeapD8O54

— European Urology (@EUplatinum) January 30, 2022

 

---

Diretriz NCCN | Câncer renal.

4 Fev, 2022 | 15:49h

Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Comprehensive Cancer Network

---

Metanálise | Terapia de deprivação androgênica, aliada à radioterapia, está associada com melhora na sobrevida livre de progressão em homens com câncer de próstata localizado.

4 Fev, 2022 | 14:34h

Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis – The Lancet Oncology (link para o resumo – $ para o texto completo)

Comentário: Effect of ADT Use and Duration in Combination With Definitive Radiotherapy for Localized Prostate Cancer – The ASCO Post

 

---

Perspectiva | Radioterapia ultra-hipofracionada para câncer de próstata localizado: até onde se pode chegar?

28 Jan, 2022 | 16:46h

Ultrahypofractionated Radiotherapy for Localised Prostate Cancer: How Far Can We Go? – Clinical Oncology

---

M-A | Efeitos renais tardios da preservação de néfrons vs. nefrectomia radical para tumor de Wilms.

28 Jan, 2022 | 16:00h

Late Kidney Effects of Nephron-Sparing vs Radical Nephrectomy for Wilms Tumor: A Systematic Review and Meta-Analysis – The Journal of Urology (link para o resumo – $ para o texto completo)

---

Diretriz de prática clínica ESMO-EURACAN | Diagnóstico, tratamento e seguimento dos tumores seminoma e não seminoma testicular.

25 Jan, 2022 | 14:53h

Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up – Annals of Oncology

---

M-A | Variantes patogênicas do BRCA1 e BRCA2 e risco de câncer de próstata.

25 Jan, 2022 | 14:32h

BRCA1 and BRCA2 pathogenic variants and prostate cancer risk: systematic review and meta-analysis – British Journal of Cancer

---

Revisão | Risco de câncer de próstata em homens de diferentes ancestrais genéticos e abordagens do rastreamento e do tratamento da doença nesses grupos.

25 Jan, 2022 | 14:31h

Prostate cancer risk in men of differing genetic ancestry and approaches to disease screening and management in these groups – British Journal of Cancer

---

Revisão | Exames de imagem no câncer de próstata.

20 Jan, 2022 | 20:45h

Imaging of Prostate Cancer – Deutsches Ärzteblatt International

Conteúdos relacionados:

ASCO Guideline: Optimum Imaging Strategies for Advanced Prostate Cancer

RCT: MRI can cut overdiagnoses in prostate-cancer screening by half.

RCT: MRI-targeted biopsy safely reduces the need for biopsy in more than one-third of men at risk for prostate cancer

Meta-Analysis: Negative Predictive Value of MRI in the Detection of Clinically Significant Prostate Cancer

Study: MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis

Review: The Use of MRI and PET Imaging Studies for Prostate Cancer Management

Meta-Analysis: MRI plus Targeted Biopsy vs. Systematic Biopsy Alone for the Diagnosis of Prostate Cancer

Cochrane Review: MRI Pathway vs. Systematic Biopsy for Detecting Prostate Cancer

RCT: Inclusion of 18F-fluciclovine-PET/CT imaging to guide postprostatectomy salvage radiotherapy in patients with prostate cancer may improve survival free from biochemical recurrence or persistence.

Meta-analysis: Clinical Utility of MRI in the Decision-making Process Before Radical Prostatectomy

Research: Biparametric MRI (simpler, faster) May Be Used to Exclude Aggressive Disease and Avoid Unnecessary Biopsies in Men with Clinical Suspicion of Prostate Cancer

Research: MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

Multiparametric MRI in the Detection of Clinically Significant Prostate Cancer

---